Feature Channels: Infectious Diseases

Filters close
Released: 7-May-2021 1:40 PM EDT
There is no evidence that vaccines could cause harm to people who have recovered from COVID-19
Newswise

An article published by Robert F. Kennedy Jr.’s anti-vaccination organization and widely shared on social media questions the need of vaccinating those who’ve already recovered from COVID-19. The article says there’s a "potential risk of harm, including death" in getting the vaccines. We report this claim as false. There is no evidence that vaccinating people who had previously had COVID is resulting in an increased risk of adverse events.

access_time Embargo lifts in 2 days
Embargo will expire: 11-May-2021 11:00 AM EDT Released to reporters: 7-May-2021 1:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 11-May-2021 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 11-May-2021 11:00 AM EDT Released to reporters: 7-May-2021 10:40 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 11-May-2021 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 6-May-2021 4:20 PM EDT
How to Win Over Vaccine Skeptics: Live Expert Panel for May 20, 3pm ET
Newswise

How to Win Over Vaccine Skeptics: Live Expert Panel for May 20, 3pm ET

Released: 6-May-2021 2:15 PM EDT
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
Front Line COVID-19 Critical Care Alliance (FLCCC Alliance)

After the Most Comprehensive Review to Date, a Panel of Leading Medical Experts Conclude that Ivermectin Should be Systematically and Globally Adopted for the Prevention and Treatment of COVID-19

Released: 6-May-2021 2:10 PM EDT
儿童同样面临COVID-19的长期影响
Mayo Clinic

COVID-19感染可能对部分儿童和青少年,以及成人的健康产生长期影响。虽然大多数COVID-19儿童感染者症状轻微或根本没有症状,但对于任何COVID-19感染者而言,即使病情轻微或没有症状,感染也可能产生长期影响。

Newswise: Biopreparedness Expert Gustavo Palacios, PhD, to Join Mount Sinai, Strengthening Research Collaborations with Department of Defense
Released: 6-May-2021 1:55 PM EDT
Biopreparedness Expert Gustavo Palacios, PhD, to Join Mount Sinai, Strengthening Research Collaborations with Department of Defense
Mount Sinai Health System

Virologist Gustavo Palacios, PhD, is joining the Icahn School of Medicine at Mount Sinai from the United States Army Medical Research Institute of Infectious Diseases (USAMRIID), where he led the application and development of molecular epidemiology to advance the field of biopreparedness. Dr. Palacios will strengthen existing research collaborations between Icahn Mount Sinai and the United States Army-Department of Defense (DoD), laying a foundation for joint research initiatives to protect national and global public health.

Released: 6-May-2021 1:50 PM EDT
الأطفال أيضًا يواجهون آثارًا طويلة المدى لفيروس كورونا المستجد (كوفيد-19)
Mayo Clinic

مدينة روتشستر، ولاية مينيسوتا ― تؤثر الآثار طويلة المدى لعدوى فيروس كورونا المستجد (كوفيد-19) على صحة بعض الأطفال والمراهقين، وكذا البالغين. في حين أن معظم الأطفال المصابين بعدوى فيروس كورونا المستجد (كوفيد-19) يعانون من أعراض خفيفة أو لا تظهر عليهم أي أعراض على الإطلاق، فإن أي شخص أصيب بفيروس كورونا المستجد (كوفيد-19) - حتى لو كان المرض خفيفًا أو لم تظهر عليه أعراض - قد يُصاب بآثار طويلة المدى.

Released: 6-May-2021 1:35 PM EDT
As crianças também enfrentam efeitos de longo prazo da COVID-19
Mayo Clinic

Os efeitos de longo prazo da infecção por COVID-19 estão afetando a saúde de algumas crianças e adolescentes, bem como de adultos. Embora a maioria das crianças com infecção por COVID-19 tenha sintomas leves ou nenhum sintoma, qualquer pessoa que teve COVID-19, mesmo se leve ou sem sintomas, pode ter efeitos de longo prazo.

Newswise: New grant-funded research could help improve therapies for sepsis
Released: 6-May-2021 1:05 PM EDT
New grant-funded research could help improve therapies for sepsis
University of Kentucky

A University of Kentucky College of Medicine professor has been awarded a $1.9 million NIH grant for his research on the body’s immune response to sepsis, which could potentially help to improve therapies for the common disease.

Released: 6-May-2021 12:40 PM EDT
Achieving high COVID-19 vaccine coverage levels by summer can prevent millions of cases
CUNY Graduate School of Public Health and Health Policy

With around 30 percent of the U.S. population now fully vaccinated, the rate of daily vaccinations has started to slow, raising concerns that greater efforts and investments may be needed to reach higher coverage levels.

Released: 6-May-2021 12:30 PM EDT
Los niños también enfrentan los efectos a largo plazo de la COVID-19
Mayo Clinic

Los efectos a largo plazo de la infección por COVID-19 están repercutiendo en la salud de algunos niños y adolescentes, además de los adultos. Si bien la mayoría de los niños con infección por COVID-19 tienen síntomas leves o no tienen síntomas en absoluto, cualquier persona que haya tenido COVID-19 (incluso si la enfermedad fue leve o no tuvieron síntomas) puede tener efectos a largo plazo.

Released: 6-May-2021 12:30 PM EDT
Evidence suggests bubonic plague had long-term effect on human immunity genes
University of Colorado Anschutz Medical Campus

Scientists examining the remains of 36 bubonic plague victims from a 16th century mass grave in Germany have found the first evidence that evolutionary adaptive processes, driven by the disease, may have conferred immunity on later generations of people from the region.

Newswise: COVID-19 vaccine is associated with fewer asymptomatic SARS-CoV-2 infections
Released: 6-May-2021 11:55 AM EDT
COVID-19 vaccine is associated with fewer asymptomatic SARS-CoV-2 infections
St. Jude Children's Research Hospital

St. Jude Children’s Research Hospital COVID-19 screening and vaccination program for employees offers early evidence that vaccine protects against asymptomatic infection, which has fueled the pandemic.

Newswise: New partnership to develop a new ultra-fast test for COVID-19 antibodies
Released: 5-May-2021 4:40 PM EDT
New partnership to develop a new ultra-fast test for COVID-19 antibodies
University of Utah

The NanoSpot.AI test is estimated to be significantly less expensive to manufacture than other SARS-CoV-2 antibody tests and has the potential to be more affordable than currently available tests, making it possible to extend the test to every corner of the world. Clinical studies validating NanoSpot.AI are currently underway.

Newswise: Story Tips from Johns Hopkins Experts on COVID-19
Released: 5-May-2021 2:30 PM EDT
Story Tips from Johns Hopkins Experts on COVID-19
Johns Hopkins Medicine

How Can Scientists Predict a COVID-19 Outbreak? There's an App for that; Johns Hopkins Medicine Collaborates with the City and Faith Organizations to Offer Guidance on Safely Reopening Houses of Worship; Johns Hopkins Hospital Patient ‘Grateful to Still Be Alive’ After Two-Month Hospitalization with COVID-19; “12 Things You Need To Know” Infographic...

Newswise: Microneedles are promising devices for painless drug delivery with minimal side effects
Released: 5-May-2021 1:00 PM EDT
Microneedles are promising devices for painless drug delivery with minimal side effects
University of Helsinki

A recent study from the University of Helsinki monitors the breakthrough progresses in the development of microneedles for immunotherapy and discusses the challenges regarding their production.

Newswise: Organ Transplant Recipients Remain Vulnerable to Covid-19 Even After Second Vaccine Dose
Released: 5-May-2021 1:00 PM EDT
Organ Transplant Recipients Remain Vulnerable to Covid-19 Even After Second Vaccine Dose
Johns Hopkins Medicine

In a study published today in the Journal of the American Medical Association (JAMA), Johns Hopkins Medicine researchers show that although two doses of a vaccine against SARS-CoV-2 — the virus that causes COVID 19 — confers some protection for people who have received solid organ transplants, it’s still not enough to enable them to dispense with masks, physical distancing and other safety measures.

Released: 5-May-2021 12:50 PM EDT
Long-acting injectable medicine as potential route to COVID-19 therapy
University of Liverpool

Researchers from the University of Liverpool have shown the potential of repurposing an existing and cheap drug into a long-acting injectable therapy that could be used to treat Covid-19.

Newswise:Video Embedded covid-19-vaccine-understanding-herd-immunity-vaccine-hesitancy
VIDEO
Released: 5-May-2021 11:05 AM EDT
COVID-19 vaccine: Understanding herd immunity, vaccine hesitancy
University of Michigan

Since the beginning of the pandemic, herd immunity has been portrayed as the holy grail to overcome the COVID-19 pandemic.

Released: 5-May-2021 10:20 AM EDT
Targeted methods to control SARS-CoV-2 spread
University of Georgia

Published in the journal Proceedings of the Royal Society B, the research analyzes more palatable alternatives to the kind of social distancing mandates that threw a wrench at how businesses, schools and even family gatherings work.

Released: 5-May-2021 10:00 AM EDT
Study Finds More COVID-19 Cases, Deaths for Nursing Homes with More Black Residents
Columbia University School of Nursing

Nursing homes (NHs) with Black residents had higher rates of COVID-19 infection and deaths during the first wave of the pandemic compared to those with no Black residents, according to new research from Columbia University School of Nursing.

Newswise: Chula Innovations for Society to Fight COVID-19
Released: 5-May-2021 8:55 AM EDT
Chula Innovations for Society to Fight COVID-19
Chulalongkorn University

Chulalongkorn University has taken a bold step in commutating its transformation to an innovation-centric university with its “Innovations for Society” campaign. The campaign uses a short movie to inform the public about the various innovations that Chula has successfully developed to fight the COVID-19 pandemic, as part of Chula’s mission to play a leading role in “Creating Knowledge and Innovation to Promote Sustainable Development for Society”.

Released: 4-May-2021 12:50 PM EDT
Tip Sheet: Latest research on COVID-19, health disparities, antibodies to parainfluenza, and neuron function
Fred Hutchinson Cancer Research Center

SEATTLE — May 4, 2021 — Below are summaries of recent Fred Hutch research findings and other news.If you are covering news at the upcoming American Society of Gene & Cell Therapy, American Society of Clinical Oncology, or other conferences, feel free to reach out to our media team for help sourcing experts:

Released: 3-May-2021 3:20 PM EDT
COVID-19 conspiracy beliefs increased among users of conservative and social media
Annenberg Public Policy Center

Belief in conspiracies about the COVID-19 pandemic increased through the early months of the U.S. outbreak among people who reported being heavy users of conservative and social media, a study by Annenberg Public Policy Center (APPC) researchers has found.

Released: 3-May-2021 11:05 AM EDT
Mayo Clinic adds state-by-state vaccination rates, national trends to COVID-19 Resource Center
Mayo Clinic

Mayo Clinic data scientists have added a vaccination tracker to Mayo's COVID-19 Resource Center, with state-by-state data and trends, so users can follow the COVID-19 vaccine rollout in all 50 states, compare progress on one- and two-shot vaccinations, and receive Mayo Clinic guidance on what the trends mean for summer travel and keeping your family safe.

Newswise: 263583_web.jpg
Released: 30-Apr-2021 4:05 PM EDT
The novel coronavirus' spike protein plays additional key role in illness
Salk Institute for Biological Studies

Scientists have known for a while that SARS-CoV-2's distinctive "spike" proteins help the virus infect its host by latching on to healthy cells. Now, a major new study shows that they also play a key role in the disease itself.

Newswise: 263578_web.jpg
Released: 30-Apr-2021 11:10 AM EDT
Researchers develop chip that improves testing and tracing for COVID-19
University of New Mexico

Jeremy Edwards, director of the Computational Genomics and Technology (CGaT) Laboratory at The University of New Mexico, and his colleagues at Centrillion Technologies in Palo Alto, Calif. and West Virginia University, have developed a chip that provides a simpler and more rapid method of genome sequencing for viruses like COVID-19.

Newswise: Chula to Accelerate Research on “Rutin” — An Herbal Extract Against COVID-19
Released: 30-Apr-2021 8:55 AM EDT
Chula to Accelerate Research on “Rutin” — An Herbal Extract Against COVID-19
Chulalongkorn University

Chula researchers have found that “rutin” extract from orange peel can kill the COVID-19 virus. They are developing it into drugs while pointing out that drug research is still necessary along with vaccine research and suggesting that Thai people should adjust their views on herbs to create added value.

Newswise: University of Maryland School of Medicine Begins Pediatric Trial of Moderna COVID-19 Vaccine
Released: 29-Apr-2021 5:05 PM EDT
University of Maryland School of Medicine Begins Pediatric Trial of Moderna COVID-19 Vaccine
University of Maryland Medical Center

Researchers at the University of Maryland School of Medicine began enrolling children ages 6 months to 11 years old in a clinical trial of the Moderna mRNA-1273 COVID-19 vaccine, which has already received Food and Drug Administration Emergency Use Authorization for adults.

Newswise: International Organization Honors Renowned Rutgers Microbiologist
Released: 29-Apr-2021 3:05 PM EDT
International Organization Honors Renowned Rutgers Microbiologist
Rutgers University-New Brunswick

Martin J. Blaser, MD, has been awarded the 2020 Prize Medal by the Microbiology Society of Great Britain in recognition of his study of the microbiome and its interactions within the human body that provide protection against and lead to disease. Dr. Blaser, the Henry Rutgers Chair of the Human Microbiome and professor of medicine and microbiology at the Rutgers Robert Wood Johnson Medical School and director of the Center for Advanced Biotechnology and Medicine at Rutgers Biomedical and Health Sciences, joins a storied list of scientists, including Nobel Prize recipients, who also have been recognized with the Prize Medal due to the impact their work has had on medicine and the care of patients worldwide.

Released: 29-Apr-2021 3:05 PM EDT
In-Person Schooling with Inadequate Mitigation Measures Raises Household Member’s COVID-19 Risk
Johns Hopkins Bloomberg School of Public Health

People living with a child who attends school in-person have an increased risk of reporting evidence of COVID-19, but teacher masking, symptom screening, and other mitigation measures in schools may be able to minimize that excess risk, suggests a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

Newswise: Surfaces Can Be Designed with Antiviral Properties to Mitigate COVID-19
29-Apr-2021 2:45 PM EDT
Surfaces Can Be Designed with Antiviral Properties to Mitigate COVID-19
American Institute of Physics (AIP)

If a respiratory droplet from a person infected with COVID-19 lands on a surface, it becomes a possible source of disease spread, because while 99.9% of the droplet's liquid content evaporates within a few minutes, a residual thin film that allows the virus to survive can be left behind. In Physics of Fluids, researchers present work exploring how the evaporation rate of residual thin films can be accelerated by tuning surfaces' wettability and creating geometric microtextures on them.

Released: 29-Apr-2021 1:05 PM EDT
The claim made by leaders of Miami school that vaccinated teachers can negatively affect non-vaccinated staff and students is completely false
Newswise

There is no evidence any vaccinated people may be transmitting something from their bodies to non-vaccinated people.

Released: 29-Apr-2021 12:10 PM EDT
妙佑医疗国际(Mayo Clinic) 的计算机模型表明,提高疫苗接种率是控制COVID-19疫情的关键的所在
Mayo Clinic

妙佑医疗国际的数据科学家曾制作高精度计算机模型,用于预测美国COVID-19病例的趋势。目前,他们又开展了一项新的研究,研究结果表明,提高疫苗接种率对于减少病例和控制疫情至关重要。

Released: 29-Apr-2021 12:05 PM EDT
Una tasa alta de vacunación es clave para el curso de la pandemia de la COVID-19, según un modelo computarizado de Mayo Clinic
Mayo Clinic

Los científicos de datos de Mayo Clinic que desarrollaron un modelado computarizado de gran precisión para predecir las tendencias de los casos de COVID-19 en Estados Unidos cuentan con una investigación nueva que muestra la importancia de una tasa alta de vacunación para reducir la cantidad de casos y controlar la pandemia.

Released: 29-Apr-2021 11:25 AM EDT
The new study of emerging materials helping in detection of COVID-19
Ural Federal University

The SARS-CoV-2 virus is still causing a dramatic loss of human lives worldwide, constituting an unprecedented challenge for society, public health, and economy, to overcome.

Released: 29-Apr-2021 9:45 AM EDT
Many Hispanics died of COVID-19 because of work exposure
Ohio State University

Hispanic Americans have died of COVID-19 at a disproportionately high rate compared to whites because of workplace exposure to the virus, a new study suggests.

Newswise: How SARS-CoV-2 Hijacks Human Cells to Evade Immune System
Released: 28-Apr-2021 3:25 PM EDT
How SARS-CoV-2 Hijacks Human Cells to Evade Immune System
University of California San Diego Health

UC San Diego School of Medicine researchers discovered one way in which SARS-CoV-2 hijacks human cell machinery to blunt the immune response, allowing it to establish infection, replicate and cause disease.

Released: 28-Apr-2021 12:55 PM EDT
UM School of Medicine Helps Maryland Conduct State-Wide Sequencing of COVID Variants
University of Maryland Medical Center

Jacques Ravel, PhD In an effort to monitor the spread of COVID-19 variants in the State of Maryland, University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced that UMaryland Genomics at UMSOM will perform genome sequencing of variants in at least 10 percent of COVID-19 test samples, reaching an important benchmark set by the federal government to help control the spread of these variants.


Showing results

150 of 9501

close
6.13729